Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinjun Hou

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
PNAS Nexus|August 19, 2024
The dynamics of the midgut microbiome in <i>Aedes aegypti</i> during digestion reveal putative symbiontsJoão Felipe M Salgado, Balakrishnan N V Premkrishnan, Elaine L Oliveira, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2014
Structure-based design of novel human Pin1 inhibitors (III): optimizing affinity beyond the phosphate recognition pocketChuangxing Guo, Xinjun Hou, Liming Dong, et al.
Scientific Reports|April 11, 2019
Author Correction: Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRsNoelia Ferruz, Stefan Doerr, Michelle A Vanase-Frawley, et al.
Scientific Reports|January 19, 2018
Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRsNoelia Ferruz, Stefan Doerr, Michelle A Vanase-Frawley, et al.
Nature Communications|August 26, 2025
Predictive design of crystallographic chiral separationRokas Elijošius, Emma King-Smith, Felix A Faber, et al.
Journal of Medicinal Chemistry|February 3, 2006
Design, synthesis, and biological activity of novel polycyclic aza-amide FKBP12 ligandsRaymond A Hudack, Nancy S Barta, Chuangxing Guo, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2006
5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part III: molecular modeling studies on binding contribution of 1-(5-methylsulfonyl)pyrid-2-yl and 4-nitrileSubas M Sakya, Xinjun Hou, Martha L Minich, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2009
Structure-based design of novel human Pin1 inhibitors (I)Chuangxing Guo, Xinjun Hou, Liming Dong, et al.
Journal of Medicinal Chemistry|July 28, 2009
Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of schizophreniaPatrick R Verhoest, Douglas S Chapin, Michael Corman, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2002
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. Part 7: structure-activity studies of bicyclic 2-pyridone-containing peptidomimeticsPeter S Dragovich, Thomas J Prins, Ru Zhou, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
PNAS Nexus|August 19, 2024
The dynamics of the midgut microbiome in <i>Aedes aegypti</i> during digestion reveal putative symbiontsJoão Felipe M Salgado, Balakrishnan N V Premkrishnan, Elaine L Oliveira, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2014
Structure-based design of novel human Pin1 inhibitors (III): optimizing affinity beyond the phosphate recognition pocketChuangxing Guo, Xinjun Hou, Liming Dong, et al.
Scientific Reports|April 11, 2019
Author Correction: Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRsNoelia Ferruz, Stefan Doerr, Michelle A Vanase-Frawley, et al.
Scientific Reports|January 19, 2018
Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRsNoelia Ferruz, Stefan Doerr, Michelle A Vanase-Frawley, et al.
Nature Communications|August 26, 2025
Predictive design of crystallographic chiral separationRokas Elijošius, Emma King-Smith, Felix A Faber, et al.
Journal of Medicinal Chemistry|February 3, 2006
Design, synthesis, and biological activity of novel polycyclic aza-amide FKBP12 ligandsRaymond A Hudack, Nancy S Barta, Chuangxing Guo, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2006
5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part III: molecular modeling studies on binding contribution of 1-(5-methylsulfonyl)pyrid-2-yl and 4-nitrileSubas M Sakya, Xinjun Hou, Martha L Minich, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2009
Structure-based design of novel human Pin1 inhibitors (I)Chuangxing Guo, Xinjun Hou, Liming Dong, et al.
Journal of Medicinal Chemistry|July 28, 2009
Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of schizophreniaPatrick R Verhoest, Douglas S Chapin, Michael Corman, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2002
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. Part 7: structure-activity studies of bicyclic 2-pyridone-containing peptidomimeticsPeter S Dragovich, Thomas J Prins, Ru Zhou, et al.
Pageof 5